pharmaphorum

OCTOBER 12, 2021

A data-mining study conducted by researchers in the US has found that an already-approved diuretic drug could have potential as a treatment for some patients with Alzheimer’s disease.

Gene Expression 111

Gene Expression Drugs FDA Approval Gene 111

pharmaphorum

FEBRUARY 2, 2022

Pharming has since started exploring new uses for the drug in acute kidney injury and COVID-19 pneumonia, whilst working on a gene therapy approach for HAE with Orchard Therapeutics. As it stands, the only other candidate for the disease listed in the clinicatrials.gov database is generic drug rapamycin.

Trials 52

Trials Drugs Sales Generic Drugs 52

STAT News

FEBRUARY 14, 2023

WASHINGTON — The Biden administration on Tuesday announced three new drug pricing policy experiments that would standardize how much Medicare patients pay for certain generic drugs, pilot new ways for Medicaid to pay for pricey cell and gene therapies, and test ways to pay for drugs approved without proven clinical benefit to patients.

Drugs 98

Drugs Generic Drugs Gene Therapy Gene 98

World of DTC Marketing

JANUARY 31, 2021

So where to start… Congresswoman Porter may want to look at the percentage of generic drugs available virus branded (89%). Ex vivo (where cells are genetically modified outside the body) cell and gene therapies have generated considerable excitement on their potential to cure previously incurable diseases.

In-Vivo 187

In-Vivo Generic Drugs Drugs Gene Therapy 187

Pharmaceutical Technology

APRIL 4, 2023

Indian pharma manufacturing continues to be the backbone of drug supplies worldwide, and GlobalData analysis suggests US overreliance on the country for generic drug supply. US reliance on India for generic drugs could have supply chain security and quality implications for critical medicines.

Manufacturing 130

Manufacturing Generic Drugs Contract Manufacturing Production 130

The Pharma Data

MAY 6, 2021

CSL closes deal for UniQure gene therapy in hopeful sign for M&A ( BioPharmaDive ). Dyno raises $100 million to bring artificial intelligence to gene therapy ( STAT ). Biogen’s Alzheimer’s drug may only be cost effective at $2,500 a year ( STAT ). OcuWho? .

Sales 52

Sales Vaccine Vaccination Gene Therapy 52

XTalks

FEBRUARY 5, 2024

Alecensa is approved in Japan for the additional indication of recurrent or refractory ALK fusion gene-positive anaplastic large-cell lymphoma. Alecensa is not currently available in generic form. million the drug made during the same time in 2022. For the first three quarters of 2023, worldwide Alimta revenue was $172.6

FDA Approval 101

FDA Approval Drugs Sales Development 101